PTLF (Petlife Pharmaceuticals) Pretax Margin %: % (As of Feb. 2018)


What is Petlife Pharmaceuticals Pretax Margin %?

Petlife Pharmaceuticals PTLF Pretax Margin % is % as of Feb. 2018.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Petlife Pharmaceuticals's Pre-Tax Income for the three months ended in Feb. 2018 was $-0.43 Mil. Petlife Pharmaceuticals's Revenue for the three months ended in Feb. 2018 was $0.00 Mil. Therefore, Petlife Pharmaceuticals's pretax margin for the quarter that ended in Feb. 2018 was %.

The historical rank and industry rank for Petlife Pharmaceuticals's Pretax Margin % or its related term are showing as below:


PTLF's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.295
* Ranked among companies with meaningful Pretax Margin % only.

Petlife Pharmaceuticals  (OTCPK:PTLF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Petlife Pharmaceuticals Pretax Margin % Related Terms

Petlife Pharmaceuticals Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Pretax Margin % Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PTLF vs PCYN, YBAO, BKIT: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Petlife Pharmaceuticals Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's Pretax Margin % falls into.


Petlife Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Petlife Pharmaceuticals's Pretax Margin for the fiscal year that ended in Aug. 2017 is calculated as

Pretax Margin=Pre-Tax Income (A: Aug. 2017 )/Revenue (A: Aug. 2017 )
=-23.257/0
= %

Petlife Pharmaceuticals's Pretax Margin for the quarter that ended in Feb. 2018 is calculated as

Pretax Margin=Pre-Tax Income (Q: Feb. 2018 )/Revenue (Q: Feb. 2018 )
=-0.427/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Petlife Pharmaceuticals (PTLF) has a Pretax Margin % of % as of Feb. 2018. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Pretax Margin % too high?
Petlife Pharmaceuticals' current Pretax Margin % is %.
How does Petlife Pharmaceuticals' Pretax Margin % compare to PCYN and YBAO?
Petlife Pharmaceuticals' Pretax Margin % of % can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Petlife Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Petlife Pharmaceuticals's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Pretax Margin % is % as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.